PURPOSE: A mouse mutant identified during a recessive N-ethyl-N-nitrosourea (ENU) mutagenesis screen exhibited ocular hemorrhaging resulting in a blood-filled orbit, and hence was named "redeye." We aimed to identify the causal mutation in redeye, and evaluate it as a model for diabetic retinopathy (DR). METHODS: The causative gene mutation in redeye was identified by haplotype mapping followed by exome sequencing. Glucose tolerance tests, detailed histologic and immunofluorescence analyses, and vascular permeability assays were performed to determine the affect of redeye on glucose metabolism, pericyte recruitment, and the development of the retinal vasculature and blood-retinal barrier (BRB). RESULTS: A mutation was identified in the Pdgfrb gene at position +2 of intron 6. We show that this change causes partial loss of normal splicing resulting in a frameshift and premature termination, and, therefore, a substantial reduction in normal Pdgfrb transcript. The animals exhibit defective pericyte recruitment restricted to the central nervous system (CNS) causing basement membrane and vascular patterning defects, impaired vascular permeability, and aberrant BRB development, resulting in vascular leakage and retinal ganglion cell apoptosis. Despite exhibiting classic features of diabetic retinopathy, redeye glucose tolerance is normal. CONCLUSIONS: The Pdgfrb(redeye/redeye) mice exhibit all of the features of nonproliferative DR, including retinal neurodegeneration. In addition, the perinatal onset of the CNS-specific vascular phenotype negates the need to age animals or manage diabetic complications in other organs. Therefore, they are a more useful model for diseases involving pericyte deficiencies, such as DR, than those currently being used.
PURPOSE: A mouse mutant identified during a recessive N-ethyl-N-nitrosourea (ENU) mutagenesis screen exhibited ocular hemorrhaging resulting in a blood-filled orbit, and hence was named "redeye." We aimed to identify the causal mutation in redeye, and evaluate it as a model for diabetic retinopathy (DR). METHODS: The causative gene mutation in redeye was identified by haplotype mapping followed by exome sequencing. Glucose tolerance tests, detailed histologic and immunofluorescence analyses, and vascular permeability assays were performed to determine the affect of redeye on glucose metabolism, pericyte recruitment, and the development of the retinal vasculature and blood-retinal barrier (BRB). RESULTS: A mutation was identified in the Pdgfrb gene at position +2 of intron 6. We show that this change causes partial loss of normal splicing resulting in a frameshift and premature termination, and, therefore, a substantial reduction in normal Pdgfrb transcript. The animals exhibit defective pericyte recruitment restricted to the central nervous system (CNS) causing basement membrane and vascular patterning defects, impaired vascular permeability, and aberrant BRB development, resulting in vascular leakage and retinal ganglion cell apoptosis. Despite exhibiting classic features of diabetic retinopathy, redeye glucose tolerance is normal. CONCLUSIONS: The Pdgfrb(redeye/redeye) mice exhibit all of the features of nonproliferative DR, including retinal neurodegeneration. In addition, the perinatal onset of the CNS-specific vascular phenotype negates the need to age animals or manage diabetic complications in other organs. Therefore, they are a more useful model for diseases involving pericyte deficiencies, such as DR, than those currently being used.
Entities:
Keywords:
PdgfrB; diabetic retinopathy; mouse model
Authors: Pedro Geraldes; Junko Hiraoka-Yamamoto; Motonobu Matsumoto; Allen Clermont; Michael Leitges; Andre Marette; Lloyd P Aiello; Timothy S Kern; George L King Journal: Nat Med Date: 2009-11-01 Impact factor: 53.440
Authors: Remya Robinson; Veluchamy A Barathi; Shyam S Chaurasia; Tien Y Wong; Timothy S Kern Journal: Dis Model Mech Date: 2012-07 Impact factor: 5.758
Authors: Andrew K Edwards; Kyle Glithero; Peter Grzesik; Alison A Kitajewski; Naikhoba Co Munabi; Krista Hardy; Qian Kun Tan; Michael Schonning; Thaned Kangsamaksin; Jan K Kitajewski; Carrie J Shawber; June K Wu Journal: JCI Insight Date: 2017-11-02
Authors: Ryan P Liegel; Mark T Handley; Adam Ronchetti; Stephen Brown; Lars Langemeyer; Andrea Linford; Bo Chang; Deborah J Morris-Rosendahl; Sarah Carpanini; Renata Posmyk; Verity Harthill; Eamonn Sheridan; Ghada M H Abdel-Salam; Paulien A Terhal; Francesca Faravelli; Patrizia Accorsi; Lucio Giordano; Lorenzo Pinelli; Britta Hartmann; Allison D Ebert; Francis A Barr; Irene A Aligianis; Duska J Sidjanin Journal: Am J Hum Genet Date: 2013-11-14 Impact factor: 11.025
Authors: Bo Chen; Bogale Aredo; Yi Ding; Xin Zhong; Yuanfei Zhu; Cynthia X Zhao; Ashwani Kumar; Chao Xing; Laurent Gautron; Stephen Lyon; Jamie Russell; Xiaohong Li; Miao Tang; Priscilla Anderton; Sara Ludwig; Eva Marie Y Moresco; Bruce Beutler; Rafael L Ufret-Vincenty Journal: Proc Natl Acad Sci U S A Date: 2020-05-26 Impact factor: 11.205
Authors: Andrea Trost; Simona Lange; Falk Schroedl; Daniela Bruckner; Karolina A Motloch; Barbara Bogner; Alexandra Kaser-Eichberger; Clemens Strohmaier; Christian Runge; Ludwig Aigner; Francisco J Rivera; Herbert A Reitsamer Journal: Front Cell Neurosci Date: 2016-02-04 Impact factor: 5.505
Authors: Nundehui Díaz-Lezama; Anne Wolf; Susanne Koch; Anna M Pfaller; Josef Biber; Xavier Guillonneau; Thomas Langmann; Antje Grosche Journal: Int J Mol Sci Date: 2021-01-25 Impact factor: 5.923
Authors: Michael Vanlandewijck; Thibaud Lebouvier; Maarja Andaloussi Mäe; Khayrun Nahar; Simone Hornemann; David Kenkel; Sara I Cunha; Johan Lennartsson; Andreas Boss; Carl-Henrik Heldin; Annika Keller; Christer Betsholtz Journal: PLoS One Date: 2015-11-23 Impact factor: 3.240